<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">pmj</journal-id><journal-title-group><journal-title xml:lang="ru">Тихоокеанский медицинский журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Pacific Medical Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1609-1175</issn><publisher><publisher-name>TGMU</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.34215/1609-1175-2022-3-85-87</article-id><article-id custom-type="elpub" pub-id-type="custom">pmj-2367</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>НАБЛЮДЕНИЯ ИЗ ПРАКТИКИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PRACTICE OBSERVATIONS</subject></subj-group></article-categories><title-group><article-title>Клинические проявления и тактика хирургического лечения злокачественной глаукомы пациентов с псевдофакией</article-title><trans-title-group xml:lang="en"><trans-title>Clinical manifestations and surgical tactics in the treatment of malignant glaucoma in pseudophakia patients</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хван</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Khvan</surname><given-names>D. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Владивосток</p></bio><bio xml:lang="en"><p>ophthalmologist of Diagnostic Department, </p><p>100e, Borisenko Str., Vladivostok, 690088</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Приморский центр микрохирургии глаза</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Primorskiy Center of Eye Microsurgery</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>08</day><month>09</month><year>2022</year></pub-date><volume>0</volume><issue>3</issue><fpage>85</fpage><lpage>87</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Хван Д.А., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Хван Д.А.</copyright-holder><copyright-holder xml:lang="en">Khvan D.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.tmj-vgmu.ru/jour/article/view/2367">https://www.tmj-vgmu.ru/jour/article/view/2367</self-uri><abstract><p>Злокачественная глаукома является одной из самых грозных осложнений глазной хирургии, которая ведет к необратимой слепоте. Частота встречаемости после полостных операций с закрытоугольной глаукомой колеблется от 0,4 до 8%. В данной статье описаны факторы риска, клинические проявления и лечение данной патологии. </p></abstract><trans-abstract xml:lang="en"><p>Malignant glaucoma is one of the most serious complications of eye surgery, which may progress to permanent blindness. The incidence of malignant glaucoma after eye surgery in patients with angle-closure glaucoma ranges from 0.4 to 8%. The article describes the risk factors and clinical manifestations of this pathology and existing treatment approaches. </p></trans-abstract><kwd-group xml:lang="ru"><kwd>глаукома</kwd><kwd>злокачественная</kwd><kwd>витреальный блок</kwd><kwd>синехии</kwd></kwd-group><kwd-group xml:lang="en"><kwd>glaucoma</kwd><kwd>malignant</kwd><kwd>vitreaous block</kwd><kwd>synechia</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Foreman-Larkin J, Netland PA, Salim S. Clinical Management of Malignant Glaucoma. Journal of Ophthalmology. 2015;2015: 283707. doi: 10.1155/2015/283707</mixed-citation><mixed-citation xml:lang="en">Foreman-Larkin J, Netland PA, Salim S. Clinical Management of Malignant Glaucoma. Journal of Ophthalmology. 2015;2015: 283707. doi: 10.1155/2015/283707</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Shahid H, Salmon JF. Malignant Glaucoma: A Review of the Modern Literature. Journal of Ophthalmology. 2012;2012:852659. doi: 10.1155/2012/852659</mixed-citation><mixed-citation xml:lang="en">Shahid H, Salmon JF. Malignant Glaucoma: A Review of the Modern Literature. Journal of Ophthalmology. 2012;2012:852659. doi: 10.1155/2012/852659</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Alsarhani WK, Almater AI, Abouammoh MA, Almobarak FA. Successful Pars Plana Vitrectomy with Zonulo-hyaloidectomy Performed 4 Years after the Onset of Chronic Low-Grade Aqueous Misdirection. Middle East African Journal of Ophthalmology. 2021;28(2):137–9. doi: 10.4103/meajo.meajo_19_21</mixed-citation><mixed-citation xml:lang="en">Alsarhani WK, Almater AI, Abouammoh MA, Almobarak FA. Successful Pars Plana Vitrectomy with Zonulo-hyaloidectomy Performed 4 Years after the Onset of Chronic Low-Grade Aqueous Misdirection. Middle East African Journal of Ophthalmology. 2021;28(2):137–9. doi: 10.4103/meajo.meajo_19_21</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Chew RP, Chong AI, Zamli AH, Muhammed J. Successful Management of Malignant Glaucoma With Irido-Zonulo-Hyaloidotomy and Complete Pars Plana Vitrectomy. Cureus. 2022; 14(1):e21679. doi: 10.7759/cureus.21679</mixed-citation><mixed-citation xml:lang="en">Chew RP, Chong AI, Zamli AH, Muhammed J. Successful Management of Malignant Glaucoma With Irido-Zonulo-Hyaloidotomy and Complete Pars Plana Vitrectomy. Cureus. 2022; 14(1):e21679. doi: 10.7759/cureus.21679</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Grzybowski A, Kanclerz P. Acute and chronic fluid misdirection syndrome: pathophysiology and treatment. Graefe’s archive for clinical and experimental ophthalmology. 2018;256(1):135–54. doi: 10.1007/s00417-017-3837-0</mixed-citation><mixed-citation xml:lang="en">Grzybowski A, Kanclerz P. Acute and chronic fluid misdirection syndrome: pathophysiology and treatment. Graefe’s archive for clinical and experimental ophthalmology. 2018;256(1):135–54. doi: 10.1007/s00417-017-3837-0</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Chean CS, Gabadage D, Mukherji S. Aqueous misdirection syndrome masking as myopic surprise following phacoemulsification surgery. BMJ Cas Rep. 2021;14(12):e242777. doi: 10.1136/bcr-2021-242777</mixed-citation><mixed-citation xml:lang="en">Chean CS, Gabadage D, Mukherji S. Aqueous misdirection syndrome masking as myopic surprise following phacoemulsification surgery. BMJ Cas Rep. 2021;14(12):e242777. doi: 10.1136/bcr-2021-242777</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Chandler PA. Malignant Glaucoma. Transactions of the American Ophthalmological Society. 1950;48:128–43.</mixed-citation><mixed-citation xml:lang="en">Chandler PA. Malignant Glaucoma. Transactions of the American Ophthalmological Society. 1950;48:128–43.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Simmons RJ. Malignant glaucoma. British Journal of Ophthalmology. 1972 Mar;56(3):263–72. doi: 10.1136/bjo.56.3.263</mixed-citation><mixed-citation xml:lang="en">Simmons RJ. Malignant glaucoma. British Journal of Ophthalmology. 1972 Mar;56(3):263–72. doi: 10.1136/bjo.56.3.263</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Межнациональное руководство по глаукоме. Том 2. Острый приступ закрытоугольной глаукомы. Под ред. Егорова Е.А. и др. М.: Издательство «Офтальмология», 2016. – С. 52–53.</mixed-citation><mixed-citation xml:lang="en">Egorov EA, editor et al. Mezhnatsionalnoe rukovodstvo po glaukome. 2nd. Ostryy pristup zakrytougolnoy glaukomy. Moskow: Izdatelstvo “Oftalmologiya”; 2016. – P. 52–53. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Федяшев Г.А., Мельников В.Я., Елисеева Е.В., Тыртышникова А.В. Хирургия глаукомы: современные подходы и фармакологическое сопровождение. Владивосток: Медицина ДВ, 2020. – С. 58–60.</mixed-citation><mixed-citation xml:lang="en">Fedyashev GA, Melnikov VYa, Eliseeva EV, Tyrtyshnikova AV. Khirurgiya glaukomy: sovremenye podkhody I farmakologicheskoe soprovozhdenie. Vladivostok: Medicina DV; 2020. – P. 58–60. (In Russ.)</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
